Due to planned maintenance GS1 UK services will be temporarily paused from 7:00pm on Friday 27 March until 5:00pm on Saturday 28 March. We will also be unable to process new members during this time.

Omnicell UK support for the Independent Medicines and Medical Devices Safety Review

Following the publication of the Cumberlege review in July, Omnicell’s UK Automation Sales Director, Ed Platt, voices his support for the review which calls for wide-ranging and radical improvements across the UK health system.

The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, published its report “First Do No Harm” on 8 July. “First Do No Harm” sets out nine major recommendations to bring much-needed help and support to those who have suffered as a result of these interventions, and to reduce the risk of avoidable harm from medicines and medical devices in the future.

Guest author

Tags

Guest opinion piece